Neurocrine Biosciences Inc (NBIX)
134.73
-0.69
(-0.51%)
USD |
NASDAQ |
Dec 23, 11:26
Neurocrine Biosciences Shareholders Equity (Quarterly): 2.719B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp | 2.017B |
| West Pharmaceutical Services Inc | 2.752B |
| AptarGroup Inc | 2.539B |
| The Cooper Companies Inc | 8.083B |
| AIM ImmunoTech Inc | 2.912M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.535B |
| Total Liabilities (Quarterly) | 816.10M |
| Current Ratio | 4.367 |
| Net Debt Paydown Yield | 0.29% |